Hechmi Louzir

Tunis, Tunisia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

The molecular landscape of peach allergy in Tunisia: new insights.

The molecular landscape of peach allergy in Tunisia: new insights.

Journal: Frontiers in immunology
Published: August 31, 2025

A deep dive into shrimp allergy: clinical spectrum of shrimp allergy in a Tunisian pilot study.

A deep dive into shrimp allergy: clinical spectrum of shrimp allergy in a Tunisian pilot study.

Journal: Frontiers in allergy
Published: January 29, 2025

Molecular allergen sensitization profile and casein threshold determination predicting the persistence of cow's milk protein allergy in Tunisia (North Africa).

Molecular allergen sensitization profile and casein threshold determination predicting the persistence of cow's milk protein allergy in Tunisia (North Africa).

Journal: Frontiers in allergy
Published: January 21, 2025

Comparative Analysis of Serum BAFF and IL-17 Levels Pre- and Post-Antipsychotic Treatment for Acute Schizophrenia.

Comparative Analysis of Serum BAFF and IL-17 Levels Pre- and Post-Antipsychotic Treatment for Acute Schizophrenia.

Journal: International journal of molecular sciences
Published: November 25, 2024

High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link.

High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link.

Journal: Antibodies (Basel, Switzerland)
Published: September 23, 2024

LmCen-/- based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia.

LmCen-/- based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia.

Journal: NPJ vaccines
Published: July 05, 2024

Correction: Salivary Antigen SP32 Is the Immunodominant Target of the Antibody Response to Phlebotomus papatasi Bites in Humans.

Correction: Salivary Antigen SP32 Is the Immunodominant Target of the Antibody Response to Phlebotomus papatasi Bites in Humans.

Journal: PLoS neglected tropical diseases
Published: July 03, 2024

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.

Journal: Vaccines
Published: June 06, 2023

Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.

Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.

Journal: The Lancet. Infectious diseases
Published: August 31, 2022

A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.

A Prospective cohort study of zoonotic cutaneous leishmaniasis in tunisia: Clinical and Immunological features and immune correlates of protection.

Journal: PLoS neglected tropical diseases
Published: March 06, 2022

A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease.

A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease.

Journal: PLoS neglected tropical diseases
Published: September 17, 2019

Activated cytotoxic T cells within zoonotic cutaneous leishmaniasis lesions.

Activated cytotoxic T cells within zoonotic cutaneous leishmaniasis lesions.

Journal: Immunity, inflammation and disease
Published: November 19, 2018
Showing 1-12 of 33

Last Updated: 09/26/2026